Skip to content

Search for Phenotype-modifying Genes in Patients With Intellectual Disabilities.

Search for Phenotype-modifying Genes in Patients With Intellectual Disabilities GWAS-2DI.

Status
Not yet recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT06706934
Acronym
GWAS-2DI
Enrollment
1400
Registered
2024-11-27
Start date
2025-03-01
Completion date
2027-07-31
Last updated
2025-02-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Intellectual Disability

Keywords

Intellectual Disability, epistatic interaction

Brief summary

Each form of intellectual disability under study is a rare disease in its own right, and it is therefore difficult to study the variability of its expression. It therefore appears necessary to study large series of patients with intellectual disabilities. The objective is to identify variants in phenotype-modifying genes in patients with intellectual disability.

Detailed description

Thanks to the contribution of NGS analyses (exome and genome analysis), the rate of etiological diagnosis in intellectual disability is currently approaching 42% in some meta-analyses. At Bordeaux University Hospital, since 2017, 700 patients have been sequenced for intellectual disability, with a diagnostic rate of 33%. In genetics, epistasis refers to the interaction between two or more genes. As part of its previous work, BIONOMEEX has developed an algorithm called GWAS-2D (genome wide association study 2 dimension) which makes it possible to observe, from a large number of samples and for a given phenotype, the relationships existing between two loci on the genome. The GWAS-2DI project involves the reanalysis of exome sequencing data from patients with intellectual disabilities at Bordeaux University Hospital, using a GWAS-2D algorithm developed by BIONOMEEX to search for phenotype-modifying genes.

Interventions

None listed

Sponsors

University Hospital, Bordeaux
Lead SponsorOTHER

Study design

Observational model
CASE_CONTROL
Time perspective
RETROSPECTIVE

Eligibility

Sex/Gender
ALL
Healthy volunteers
Yes

Inclusion criteria

* Patients with Intellectual Disability or related but not affected by them * Major or minor with autorisation of legal representative * Exome sequencing in Bordeaux University Hospital between 2018 and 2024

Exclusion criteria

* Refusal to participate in research protocols * Refusal to participate expressed following receipt of information letter.

Design outcomes

Primary

MeasureTime frameDescription
Variants in phenotype-modifying genesInclusion visitIdentifying variants in phenotype-modifying genes in patients with intellectual disability.

Secondary

MeasureTime frameDescription
Phenotypic traitsInclusion visitCorrelation phenotypic traits with additional diagnostic variants

Countries

France

Contacts

Primary ContactVincent MICHAUD, MD
vincent.michaud@chu-bordeaux.fr+33556795952

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026